60 related articles for article (PubMed ID: 22007901)
1. Possible association of medications during pregnancy with low estriol level of the triple antenatal screening test.
Sarıkaya E; Bozdağ S; Deveer R; Oğuz SS; Dilmen U; Mollamahmutoglu L
J Matern Fetal Neonatal Med; 2012 Jul; 25(7):930-3. PubMed ID: 22007901
[TBL] [Abstract][Full Text] [Related]
2. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
3. [Early warning of low maternal unconjugated estriol level by prenatal screening for fetus with X-linked ichthyosis].
Liu HY; Li J; Huang DR; Feng K; Liu JH; He QN; Guo KY; Ding GY; Lou Y; Wang Y
Zhonghua Fu Chan Ke Za Zhi; 2022 Jun; 57(6):407-412. PubMed ID: 35775247
[No Abstract] [Full Text] [Related]
4. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
5. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
6. The impact of severe hyperemesis gravidarum on the triple test screening results.
Peled Y; Melamed N; Krissi H; Eitan R; Yogev Y; Pardo J
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):637-8. PubMed ID: 21819342
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum screening for birth defects: results of a Connecticut regional program.
Benn PA; Horne D; Craffey A; Collins R; Ramsdell L; Greenstein R
Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
[TBL] [Abstract][Full Text] [Related]
9. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
[TBL] [Abstract][Full Text] [Related]
10. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
11. Placental synthesis of oestriol in Down's syndrome pregnancies.
Newby D; Aitken DA; Howatson AG; Connor JM
Placenta; 2000; 21(2-3):263-7. PubMed ID: 10736251
[TBL] [Abstract][Full Text] [Related]
12. Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters.
Zhang J; Lambert-Messerlian G; Palomaki GE; Canick JA
Prenat Diagn; 2011 Jun; 31(6):583-8. PubMed ID: 21480302
[TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening.
Palomaki GE; Knight GJ; Haddow JE; Canick JA; Wald NJ; Kennard A
Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):675-8. PubMed ID: 7682315
[TBL] [Abstract][Full Text] [Related]
14. Low estriol levels in the maternal triple-marker screen as a predictor of isolated adrenocorticotropic hormone deficiency caused by a new mutation in the TPIT gene.
Weintrob N; Drouin J; Vallette-Kasic S; Taub E; Marom D; Lebenthal Y; Klinger G; Bron-Harlev E; Shohat M
Pediatrics; 2006 Feb; 117(2):e322-7. PubMed ID: 16390921
[TBL] [Abstract][Full Text] [Related]
15. Second-trimester maternal serum analyte levels associated with fetal trisomy 13.
Saller DN; Canick JA; Blitzer MG; Palomaki GE; Schwartz S; Blakemore KJ; Haddow JE
Prenat Diagn; 1999 Sep; 19(9):813-6. PubMed ID: 10521837
[TBL] [Abstract][Full Text] [Related]
16. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
17. [Study on key techniques and intervention in reducing birth defects].
Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
[TBL] [Abstract][Full Text] [Related]
18. Second-trimester maternal serum CA-125 versus estriol in the multiple-marker screening test for Down syndrome.
Wenstrom KD; Owen J; Boots L
Obstet Gynecol; 1997 Mar; 89(3):359-63. PubMed ID: 9052585
[TBL] [Abstract][Full Text] [Related]
19. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
20. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
